97 percent of UK doctors have given placebos to patients at least once

March 20, 2013 in Medications

A survey of UK doctors found that 97% have prescribed placebo treatments to patients at least once in their career.

Researchers at the Universities of Oxford and Southampton in the UK discovered that 97% of doctors have used 'impure' placebo treatments, while 12% have used 'pure' placebos.

'Impure' placebos are treatments that are unproven, such as antibiotics for suspected , or more commonly non-essential and blood tests performed to reassure patients. 'Pure' placebos are treatments such as sugar pills or saline injections which contain no .

A random sample of doctors was surveyed online, and returned 783 responses. This sample was found to be representative of all UK doctors registered with the General Medical Council (GMC). The research was funded by the National Institute for Health Research, the University of Oxford Department of Sciences and The Southampton Complementary Medical Research Trust. The results are published in the open-access journal PLOS ONE.

'This is not about doctors deceiving patients,' says Dr Jeremy Howick, co-lead author of the study from the University of Oxford, 'The study shows that placebo use is widespread in the UK, and doctors clearly believe that placebos can help patients.'

The survey showed that doctors prescribing both pure and impure placebos reported doing so for broadly similar reasons. Placebos were mainly given to either induce effects, because patients requested treatment or to reassure patients.

Ethical attitudes towards placebo usage varied among doctors, with 66% saying that pure placebos are ethically acceptable under certain circumstances and 33% saying they are never acceptable. Impure placebos were more widely accepted, with 84% of doctors deeming them acceptable.

This widespread use and acceptance of placebos is consistent with similar studies worldwide, yet they are still against ethical codes. 'Current ethical rulings on placebos ought to be revisited in light of the strong evidence suggesting that doctors broadly support their use,' says Dr Howick.

For both pure and impure placebos, over 90% of doctors objected to their use where it endangered patient/doctor trust and over 80% were against using them if it involved deception.

'This latest study with the University of Oxford demonstrates that are generally using placebos in good faith to help patients,' says Professor George Lewith, co-lead author of the study from the University of Southampton, 'Other previous published studies by Southampton have clearly shown placebos can help many people and can be effective for a long time after administration. The placebo effect works by releasing our body's own natural painkillers into our nervous system. In my opinion the stigma attached to placebo use is irrational, and further investigation is needed to develop ethical, cost-effective placebos.'

More information: dx.plos.org/10.137… pone.0058247

Journal reference: PLoS ONE search and more info website

Provided by Oxford University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Medications created 17 hours ago | popularity not rated yet | comments 0

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created May 23, 2013 | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created May 23, 2013 | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.